BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32946917)

  • 1. Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19.
    Gandini O; Criniti A; Ballesio L; Giglio S; Galardo G; Gianni W; Santoro L; Angeloni A; Lubrano C
    J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32946917
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
    Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
    PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.
    Tepasse PR; Vollenberg R; Fobker M; Kabar I; Schmidt H; Meier JA; Nowacki T; Hüsing-Kabar A
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report.
    Eleuteri D; Montini L; Cutuli SL; Rossi C; Alcaro F; Antonelli M
    Crit Care; 2021 Mar; 25(1):91. PubMed ID: 33648544
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarkers of acute respiratory distress syndrome in adults hospitalised for severe SARS-CoV-2 infection in Tenerife Island, Spain.
    Figueira Gonçalves JM; Hernández Pérez JM; Acosta Sorensen M; Wangüemert Pérez AL; Martín Ruiz de la Rosa E; Trujillo Castilla JL; Díaz Pérez D; Ramallo-Fariña Y
    BMC Res Notes; 2020 Dec; 13(1):555. PubMed ID: 33298124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.
    Ma A; Cheng J; Yang J; Dong M; Liao X; Kang Y
    Crit Care; 2020 Jun; 24(1):288. PubMed ID: 32503668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.
    Venet F; Cour M; Rimmelé T; Viel S; Yonis H; Coudereau R; Amaz C; Abraham P; Monard C; Casalegno JS; Brengel-Pesce K; Lukaszewicz AC; Argaud L; Monneret G;
    Crit Care; 2021 Apr; 25(1):140. PubMed ID: 33845874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of diagnostic value of ferritin in patients with COVID-19.
    Szarpak L; Zaczynski A; Kosior D; Bialka S; Ladny JR; Gilis-Malinowska N; Smereka J; Kanczuga-Koda L; Gasecka A; Filipiak KJ; Jaguszewski MJ
    Cardiol J; 2020; 27(6):886-887. PubMed ID: 33346371
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk Factors and a Scoring System to Predict ARDS in Patients with COVID-19 Pneumonia in Korea: A Multicenter Cohort Study.
    Seo JW; Kim SE; Choi EY; Hong KS; Oh TH; Kim UJ; Kang SJ; Park KH; Jung SI; Kim DY; Yun NR; Kim DM; Kim HP; Hur J; Jang HC
    Dis Markers; 2021; 2021():8821697. PubMed ID: 33897912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary embolism among critically ill patients with ARDS due to COVID-19.
    Soumagne T; Winiszewski H; Besch G; Mahr N; Senot T; Costa P; Grillet F; Behr J; Mouhat B; Mourey G; Fournel A; Meneveau N; Samain E; Capellier G; Piton G; Pili-Floury S
    Respir Med Res; 2020 Nov; 78():100789. PubMed ID: 33022510
    [No Abstract]   [Full Text] [Related]  

  • 12. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
    Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19.
    Razazi K; Arrestier R; Haudebourg AF; Botterel F; Mekontso Dessap A;
    Crit Care; 2021 Sep; 25(1):348. PubMed ID: 34565429
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.
    Chiscano-Camón L; Ruiz-Rodriguez JC; Ruiz-Sanmartin A; Roca O; Ferrer R
    Crit Care; 2020 Aug; 24(1):522. PubMed ID: 32847620
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases.
    Kappert K; Jahić A; Tauber R
    Biomarkers; 2020 Dec; 25(8):616-625. PubMed ID: 32700561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study.
    Monreal E; Maza S S; Gullón P; Natera-Villalba E; Chico-García JL; Beltrán-Corbellini Á; Martínez-Sanz J; García-Barragán N; Buisán J; Toledano R; Alonso-Canovas A; Pérez-Torre P; Matute-Lozano MC; López-Sendón JL; García-Ribas G; Corral Í; Fortún J; Montero-Errasquín B; Manzano L; Máiz-Carro L; Costa-Frossard L; Masjuan J;
    J Med Virol; 2021 Apr; 93(4):2243-2251. PubMed ID: 33165922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferritin as a Marker of Severity in COVID-19 Patients: A Fatal Correlation.
    Dahan S; Segal G; Katz I; Hellou T; Tietel M; Bryk G; Amital H; Shoenfeld Y; Dagan A
    Isr Med Assoc J; 2020 Aug; 22(8):494-500. PubMed ID: 33236582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
    Loscocco GG; Malandrino D; Barchiesi S; Berni A; Poggesi L; Guglielmelli P; Vannucchi AM
    Int J Lab Hematol; 2020 Dec; 42(6):e270-e273. PubMed ID: 32776691
    [No Abstract]   [Full Text] [Related]  

  • 19. Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19.
    Balfanz P; Hartmann B; Müller-Wieland D; Kleines M; Häckl D; Kossack N; Kersten A; Cornelissen C; Müller T; Daher A; Stöhr R; Bickenbach J; Marx G; Marx N; Dreher M
    PLoS One; 2021; 16(1):e0246182. PubMed ID: 33513168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
    Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.